Results 231 to 240 of about 3,662,867 (341)
Impact of Hepatitis C Virus Clearance on Cardiovascular Risk: A Real‐World Experience From the Nationwide Taiwan Hepatitis C Virus Registry
The Kaohsiung Journal of Medical Sciences, EarlyView.ABSTRACT
Hepatitis C virus (HCV) infection is associated with an increased risk of cardiovascular disease (CVD); however, the impact of interferon (IFN)‐based therapy on cardiovascular outcomes remains unclear. This nationwide cohort study included 7411 patients with HCV from The Taiwanese Chronic Hepatitis C Cohort registry who received IFN‐based ...Ping‐Jen Hu, Pei‐Chien Tsai, Chi‐Yi Chen, Hsing‐Tao Kuo, Chao‐Hung Hung, Kuo‐Chih Tseng, Hsueh‐Chou Lai, Cheng‐Yuan Peng, Jing‐Houng Wang, Jyh‐Jou Chen, Pei‐Lun Lee, Rong‐Nan Chien, Chi‐Chieh Yang, Gin‐Ho Lo, Jia‐Horng Kao, Chun‐Jen Liu, Chen‐Hua Liu, Sheng‐Lei Yan, Chun‐Yen Lin, Wei‐Wen Su, Cheng‐Hsin Chu, Chih‐Jen Chen, Shui‐Yi Tung, Chi‐Ming Tai, Chih‐Wen Lin, Ching‐Chu Lo, Pin‐Nan Cheng, Yen‐Cheng Chiu, Chia‐Chi Wang, Jin‐Shiung Cheng, Wei‐Lun Tsai, Han‐Chieh Lin, Yi‐Hsiang Huang, Ming‐Lun Yeh, Chung‐Feng Huang, Meng‐Hsuan Hsieh, Jee‐Fu Huang, Chia‐Yen Dai, Wan‐Long Chung, Yen‐Hsiange Wang, Ming‐Lung Yu, Ming‐Jong Bair, T‐COACH Study Group +42 morewiley +1 more sourceHypoxia‐Enhanced Wharton's Jelly Mesenchymal Stem Cell Therapy for Liver Fibrosis: A Comparative Study in a Rat Model
The Kaohsiung Journal of Medical Sciences, EarlyView.ABSTRACT
Liver fibrosis is a progressive disease that can lead to cirrhosis and liver failure, with limited treatment options. Wharton's jelly‐derived MSCs (WJ‐MSCs) have immunomodulatory and antifibrotic potential. Hypoxia preconditioning enhances MSC survival and paracrine activity, but its effects in liver fibrosis remain unclear.Wei‐Ting Kuo, Chen‐Yuan Hsiao, Sheng‐Hao Chiu, Shu‐Cheng Chou, Ching‐Shu Chiang, Jui‐Yu Chen, Solomon Chih‐Cheng Chen, Tien‐Hua Chen, Jia‐Fwu Shyu, Chi‐Hung Lin, Pei‐Jiun Tsai +10 morewiley +1 more sourceDecisions About Suppressive Antibiotics Among Clinicians at Veterans Affairs Hospitals After Prosthetic Joint Infection.
JAMA Netw OpenDukes KC, Walhof JF, Hockett Sherlock S, Suh D, Sekar P, Suzuki H, Reisinger HS, Alexander B, Miell KR, Beck B, Pugely A, Schweizer ML. +11 moreeuropepmc +1 more sourceClinical impact of pharmacogenetic risk variants in a large chinese cohort. [PDF]
Nat CommunWei CY, Wen MS, Cheng CK, Sheen YJ, Yao TC, Lee SL, Wu JY, Tsai MF, Li LH, Chen CH, Fann CS, Yang HC, Huang YT, Chen HH, Liu YM, Yeh EC, Peng YC, Wang SJ, Chen SP, Tsai MT, Huo TI, Su CW, Tarng DC, Huang CC, Fuh JL, Lan KH, Liu YT, Lu CL, Lee YC, Huang YH, Li CP, Wang YF, Hsieh YC, Chen YM, Hsiao TH, Lin CH, Chen YJ, Chen IC, Mao CL, Chang SJ, Chang YL, Liao YJ, Lai CH, Lee WJ, Tung H, Yen TT, Yen HC, Chang JH, Huang CY, Chan L, Lin YW, Hsiao BY, Hu CJ, Lin YK, Lin YF, Chang TC, Wu DC, Kan JY, Hsu CY, Chen SC, Li CC, Huang CF, Sheu CC, Yang LJ, Chen CH, Chen KM, Chang SM, Liou MS, Wang SP, Lin KT, Chuang HP, Chen YJ, Sin J, Chen YT, Chang CC, Kuo CF, Lin JC, Kuo HC, Chan TM, Lee CW, Lai JH, Luo SF, Cheng HT, Lin LY, Chang LC, Tsai CT, Kao HL, Yu JJ, Jeng JS, Chiu MC, Hong TC, Yang SF, Lu HJ, Su SC, Chu P, Li PF, Tsai CL, Tsai CK, Tang SE, Lin CM, Wu YF, Huang CY, Ling SZ, Chang CC, Lin TK, Hsiao SM, Chang CH, Chen CD, Ma GC, Chang TY, Hwang JJ, Lu CL, Kao KJ, Hung CF, Chen SS, Chen PY, Tsui K, Chen YT, Chen CH, Chien CC, Chiang HS, Chiu YL, Chen HC, Kwok PY. +123 moreeuropepmc +1 more source
